ARS Pharmaceuticals (SPRY) Selling, General & Administrative (2020 - 2026)
ARS Pharmaceuticals (SPRY) Selling, General & Administrative (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -10.08 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 2.17 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 555.10 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 493.70 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 647.70 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 17.02 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -355.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 101.25 Mn |
| 10 | ARS Pharmaceuticals | 595.78 Mn | 394.81 Mn | - | 72.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 72.20 Mn |
| Dec 31, 2025 | 59.96 Mn |
| Sep 30, 2025 | 74.75 Mn |
| Jun 30, 2025 | 54.31 Mn |
| Mar 31, 2025 | 41.10 Mn |
| Dec 31, 2024 | 35.49 Mn |
| Sep 30, 2024 | 19.28 Mn |
| Jun 30, 2024 | 8.94 Mn |
| Mar 31, 2024 | 7.96 Mn |
| Dec 31, 2023 | 6.82 Mn |
| Sep 30, 2023 | 14.98 Mn |
| Jun 30, 2023 | 13.31 Mn |
| Mar 31, 2023 | 337,000.00 |
| Dec 31, 2022 | 10.73 Mn |
| Sep 30, 2022 | 2.93 Mn |
| Jun 30, 2022 | 2.46 Mn |
| Mar 31, 2022 | 2.34 Mn |
| Dec 31, 2021 | -15.76 Mn |
| Sep 30, 2021 | 7.04 Mn |
| Jun 30, 2021 | 6.76 Mn |